Ca. Moser et al., EFFECT OF MICROENCAPSULATION ON IMMUNOGENICITY OF A BOVINE HERPES-VIRUS GLYCOPROTEIN AND INACTIVATED INFLUENZA-VIRUS IN MICE, Vaccine, 15(16), 1997, pp. 1767-1772
We previously found that aqueous-based spermine-alginate or spermine-c
hondroitin sulfate microcapsules enhanced rotavirus-specific humoral i
mmune responses after intramuscular inoculation of mice. To extend our
observations with whole, infectious rotavirus to vaccine strategies w
hich include inactivated virus and purified proteins, we determined th
e capacity of aqueous-based microcapsules to enhance virus-specific im
mune responses to bovine herpes virus type 1 glycoprotein D (BHV-1-gD)
or ether-treated influenza virus. We found that spermine-alginate mic
rocapsules decreased the quantity of BHV-1-gD necessary to induce prot
ein-specific antibodies about 5000-fold. However, spermine-alginate mi
crocapsules did not enhance influenza virus-specific antibody response
s. Microcapsules composed of spermine-chondroitin sulfate did not enha
nce either BHV-1-gD or influenza virus-specific immune responses. Poss
ible mechanisms of enhancement of virus-specific antibody responses by
microencapsulation are discussed. (C) 1997 Elsevier Science Ltd.